Investor Relations

Information for current and prospective investors in a company poised to disrupt the neurosurgical device market.

Investment Highlights

Massive Market Opportunity

The global cranial clamp market was valued at over $222M in 2018 and is projected to grow at a CAGR of 4.7%, representing a near-billion-dollar global opportunity.

Patented, Defensible IP

Our core innovation, the calibrated pin system, is patent-pending. This creates a strong barrier to entry for competitors and protects our critical advantage.

Clear Go-to-Market Strategy

We are pursuing Class II approval from Health Canada and a 510k from the FDA. Our B2B sales model targets distributors and HPS manufacturers for rapid market penetration.

High-Traction & Credibility

Secured a Letter of Intent from Johns Hopkins Medicine and interest from over 32 angel investors, validating both the product and the business model.

Experienced Leadership

Led by a renowned neurosurgeon and supported by a team with deep expertise in law, operations, and marketing within the medical field.

Clear Capital Need

Seeking investment to scale manufacturing, finalize regulatory approvals, and execute our entry into the North American market.

Become a Part of the Future

For access to our investor deck and due diligence documents, please get in touch.